Q3 2024 13F Holders as of 30 Sep 2024
-
Type / Class
-
Equity / Common Stock, par value $0.00001 per share
-
Shares outstanding
-
35,872,648
-
Total 13F shares
-
20,669,688
-
Share change
-
+20,362,700
-
Total reported value
-
$429,942,211
-
Price per share
-
$20.80
-
Number of holders
-
57
-
Value change
-
+$423,556,876
-
Number of buys
-
55
Institutional Holders of BioAge Labs, Inc. - Common Stock, par value $0.00001 per share (BIOA) as of Q3 2024
As of 30 Sep 2024,
BioAge Labs, Inc. - Common Stock, par value $0.00001 per share (BIOA) was held by
57 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
20,669,688 shares.
The largest 10 holders included
AH Capital Management, L.L.C., Sofinnova Investments, Inc., RA CAPITAL MANAGEMENT, L.P., Cormorant Asset Management, LP, SUVRETTA CAPITAL MANAGEMENT, LLC, ORBIMED ADVISORS LLC, Sands Capital Ventures, LLC, ALLIANCEBERNSTEIN L.P., RTW INVESTMENTS, LP, and Pivotal bioVenture Partners Investment Advisor LLC.
This page lists
58
institutional shareholders reporting positions in this security
for the Q3 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.